Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
about
The effects of background white noise on memory performance in inattentive school childrenThe adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorderADHD in Children Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity DisorderThe neurobiological basis of ADHDImmediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adultsNeural correlates of motor vigour and motor urgency during exerciseHabituation of reinforcer effectivenessBiological and social influences on cognitive control processes dependent on prefrontal cortexNeurobiological adaptations to violence across developmentNeuroimaging and ADHD: fMRI, PET, DTI findings, and methodological limitations.Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment?The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches.Attention-deficit/hyperactivity disorder and attention networksMagnetization transfer imaging identifies basal ganglia abnormalities in adult ADHD that are invisible to conventional T1 weighted voxel-based morphometry.Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversityPositive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disordersAcute administration of methylphenidate alters the prefrontal cortex neuronal activity in a dose-response characteristic.Effects of motivation and medication on electrophysiological markers of response inhibition in children with attention-deficit/hyperactivity disorder.Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder.The ability of the mesocortical dopamine system to operate in distinct temporal modes.COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD.Genotype and ancestry modulate brain's DAT availability in healthy humans.Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.A neurogenetic approach to impulsivityStimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report.Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidateThe Amygdala's Neurochemical Ratios after 12 Weeks Administration of 20 mg Long-acting Methylphenidate in Children with Attention Deficit and Hyperactivity Disorder: A Pilot Study Using (1)H Magnetic Resonance Spectroscopy.Body weight and ADHD: examining the role of self-regulation.Unbiased approaches to biomarker discovery in neurodegenerative diseasesBasal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder.Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto ratsDopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidatePersonality mediation of genetic effects on Attention-Deficit/Hyperactivity Disorder.The likelihood of cognitive enhancementElevated background noise in adult attention deficit hyperactivity disorder is associated with inattentionCatecholamine influences on dorsolateral prefrontal cortical networks.The attenuation of dysfunctional emotional processing with stimulant medication: an fMRI study of adolescents with ADHD.Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorderPharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
P2860
Q21203799-9F9B7AC6-6702-464C-8861-54557B5ACD72Q22241830-82F8FC15-1748-4869-9D61-528E552A16E3Q22305481-63990E53-B62E-4EEA-8E4E-37FBA3A9C30FQ24604400-68F852FC-4012-44AA-B961-4FE8A65B71E4Q26471999-3EB04D23-049C-4FF2-8946-A1F9EFDBA8D4Q26825100-2613ACB1-55F1-490A-A746-18895D24A5BCQ26864421-4C255406-A32C-463C-93FD-63680BBBE1D7Q29397599-BD9BD8D8-26B9-4F1C-A4AC-2A2AB2C29456Q30483725-A2956BDF-A249-47E1-91BD-6D76EAFCF028Q30627815-5B34661E-8013-4C15-97F8-301CAECE1B6EQ30831762-D20FF7CA-F789-48EC-8865-21391B25DE04Q31035912-06AFF5EC-F65E-47D8-B6AF-AE81AABAC1FEQ33504011-A44B6141-3AE3-4B30-8D8F-4D2C1B57FE08Q33580182-095FEBEF-2ACE-4AB6-9585-76C9F0E5F745Q33604717-FBC019C5-E60E-479F-B9C0-93976D4DCD86Q33664787-14461644-C1E4-4808-9836-5F15F0F4AA40Q33679327-DBE791EC-70CA-4EC0-B951-7BB934C5DA1EQ33754250-C7AEE3C1-2927-4C2D-A056-A13AECC4BB26Q33871808-5CAF5DA8-BA06-44F0-B0F9-140AADA9A48FQ33902047-430B5D1F-4F5A-4817-B783-9EE996D58690Q33911088-49D081AA-923E-47F4-A4E9-D26D6CABDA3AQ33985968-CC297B9B-BB59-4182-A802-BFA8A7F702E6Q34016523-2B278941-3467-443B-AAC1-45437EDDF474Q34035619-0CB77EA6-5947-4373-8927-313559737B3AQ34109904-DF14656B-7ECB-4AD4-A292-D25309654B59Q34121778-76F7A036-2330-4E1A-83C8-69C5F7D06B12Q34129852-5EB73FD4-B181-490F-9BDA-3858C9D8276EQ34576461-D639194B-806B-408D-80D0-C9E824762DBCQ34625918-D88952EE-D316-49C7-B1CC-ED4FF5346AC9Q34626510-761ABF4A-C579-4AD9-8EE4-CD58CF9086F5Q34709290-2EBC1E88-C453-4F5F-BFA9-6ACA2AF343FDQ34881236-85DEEC89-2A45-4CA6-9AFD-188C2B1B96ECQ34991378-2F8F114A-13DC-49D0-BE51-329F4F7BC1C0Q35001572-71EB4E9E-54C3-4763-967F-5AA08F61BB28Q35043146-708F0D96-B223-4EC7-9E8E-34D651D8E3ACQ35097156-3A24B557-220D-4872-BB0F-2CE6286109D7Q35132548-AD3371A5-AEEF-403A-A0F4-E4B07BB3D12BQ35188893-C0BECA51-3855-470C-910B-DD63840B2976Q35222327-D77BDD37-1B84-4894-84AD-566F297743D5Q35576598-8007CB99-2750-4D03-914E-708318A4C28E
P2860
Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Imaging the effects of methylp ...... eficit/hyperactivity disorder.
@ast
Imaging the effects of methylp ...... eficit/hyperactivity disorder.
@en
type
label
Imaging the effects of methylp ...... eficit/hyperactivity disorder.
@ast
Imaging the effects of methylp ...... eficit/hyperactivity disorder.
@en
prefLabel
Imaging the effects of methylp ...... eficit/hyperactivity disorder.
@ast
Imaging the effects of methylp ...... eficit/hyperactivity disorder.
@en
P2093
P1476
Imaging the effects of methylp ...... eficit/hyperactivity disorder.
@en
P2093
Gene-Jack Wang
Joanna S Fowler
Nora D Volkow
Yu-Shin Ding
P304
P356
10.1016/J.BIOPSYCH.2004.11.006
P407
P577
2005-01-12T00:00:00Z